0001666071-20-000208.txt : 20200720
0001666071-20-000208.hdr.sgml : 20200720
20200720184711
ACCESSION NUMBER: 0001666071-20-000208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200716
FILED AS OF DATE: 20200720
DATE AS OF CHANGE: 20200720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christiansen Andrew
CENTRAL INDEX KEY: 0001805400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 201037252
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_159528521573856.xml
FORM 4
X0306
4
2020-07-16
0
0001666071
Cardlytics, Inc.
CDLX
0001805400
Christiansen Andrew
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
0
1
0
0
Chief Financial Officer
Common Stock
2020-07-16
4
M
0
4707
24.48
A
15420
D
Common Stock
2020-07-16
4
S
0
4707
79
D
10713
D
Common Stock
2020-07-20
4
M
0
2518
24.48
A
13231
D
Common Stock
2020-07-20
4
S
0
2518
79
D
10713
D
Employee Stock Option (Right to Buy)
24.48
2020-07-16
4
M
0
4707
0
D
2027-04-01
Common Stock
4707.0
4667
D
Employee Stock Option (Right to Buy)
24.48
2020-07-20
4
M
0
2518
0
D
2027-04-01
Common Stock
2518.0
2149
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2020.
This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
/s/ Kirk L. Somers, Attorney-in-Fact
2020-07-20